Cargando…
Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737508/ https://www.ncbi.nlm.nih.gov/pubmed/36564261 http://dx.doi.org/10.1016/j.therap.2022.11.013 |
| _version_ | 1784847306872324096 |
|---|---|
| author | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
| author_facet | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
| author_sort | Mungmunpuntipantip, Rujittika |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9737508 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97375082022-12-12 Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Therapie Letter to Editor Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2022-12-10 /pmc/articles/PMC9737508/ /pubmed/36564261 http://dx.doi.org/10.1016/j.therap.2022.11.013 Text en © 2022 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editor Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence |
| title | Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence |
| title_full | Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence |
| title_fullStr | Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence |
| title_full_unstemmed | Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence |
| title_short | Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence |
| title_sort | central diabetes insipidus, hypophysitis and sars-cov-2 vaccine: correspondence |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737508/ https://www.ncbi.nlm.nih.gov/pubmed/36564261 http://dx.doi.org/10.1016/j.therap.2022.11.013 |
| work_keys_str_mv | AT mungmunpuntipantiprujittika centraldiabetesinsipidushypophysitisandsarscov2vaccinecorrespondence AT wiwanitkitviroj centraldiabetesinsipidushypophysitisandsarscov2vaccinecorrespondence |